The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 526, 311-321
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Omega-3 Eicosapentaenoic Acid Decreases CD133 Colon Cancer Stem-Like Cell Marker Expression While Increasing Sensitivity to ChemotherapyPLOS ONE, 2013
- Epidermal growth factor receptor signaling pathway involved in progestin‐resistance of human endometrial carcinoma: In a mouse modelJournal of Obstetrics and Gynaecology Research, 2012
- Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal DevelopmentCell Stem Cell, 2011
- Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem CellsCell Stem Cell, 2011
- Metformin Reverses Progestin Resistance in Endometrial Cancer Cells by Downregulating GloI ExpressionInternational Journal of Gynecological Cancer, 2011
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial CancerCancer Research, 2010
- Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistanceLaboratory Investigation, 2009
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsCancer Research, 2008
- Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cellsProceedings of the National Academy of Sciences, 2008
- Characterization of stem cell–like cancer cells in immune-competent miceBlood, 2006